File Code: Health Care Facilities and Regulation
- Sponsored By:
-
Delegates Elliott, Benson, Hubbard, Kullen, Mizeur, Morhaim,
Nathan-Pulliam, Pena-Melnyk, Rudolph, and Weldon
- Entitled:
-
Negotiated Prices for Medicare Part D Drugs
Calling on the United States Congress to pass legislation to require
the Secretary of Health and Human Services to negotiate with
pharmaceutical manufacturers the prices that may be charged for
Medicare Part D drugs.
House Action
- 2/7
- First Reading House Rules and Executive Nominations
- 3/14
- Withdrawn
Senate Action
- No Action
Sponsored by:
- Delegate Donald B. Elliott, District 4B
- Delegate Joanne C. Benson, District 24
- Delegate James W. Hubbard, District 23A
- Delegate Sue Kullen, District 27B
- Delegate Heather Mizeur, District 20
- Delegate Dan K. Morhaim, District 11
- Delegate Shirley Nathan-Pulliam, District 10
- Delegate Joseline Pena-Melnyk, District 21
- Delegate David D. Rudolph, District 34B
- Delegate Richard B. Weldon, Jr., District 3B
Bill indexed under the following Subjects:
- Congress, U.S
- Drugs -see also- Controlled Dangerous Sub; Substance Abuse
- Federal Government
- Legislation -see also- Corrective Leg; Curative Leg
- Medical Assistance
- Prices -see also- Consumer Price Index
- Bill Text (Displayed in PDF Format):
First Reading,
Third Reading, Enrolled
- Fiscal and Policy Note:
Not available at this time
- Amendments:
None offered
